Shavelson, M.D. v. California Department of Health Care Services

CourtDistrict Court, N.D. California
DecidedJune 22, 2022
Docket3:21-cv-06654
StatusUnknown

This text of Shavelson, M.D. v. California Department of Health Care Services (Shavelson, M.D. v. California Department of Health Care Services) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Shavelson, M.D. v. California Department of Health Care Services, (N.D. Cal. 2022).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA

LONNY SHAVELSON, M.D., et al., Case No. 21-cv-06654-VC

Plaintiffs, ORDER GRANTING MOTIONS TO v. DISMISS

ROBERT BONTA, et al., Re: Dkt. Nos. 46, 48 Defendants.

California’s End of Life Option Act gives some terminally ill Californians the ability to end their lives with aid-in-dying medication. The Act provides peace of mind to many people who would otherwise face a prolonged and painful death. But the Act does not help everyone. Sandra Morris is in the final stages of a neurodegenerative disease that will eventually claim her life. While she can currently take advantage of the relief provided by the Act, she knows she will lose this opportunity soon: She is imminently at risk of losing the ability to administer aid-in- dying medication on her own—a requirement under the Act. Morris, alongside the doctors who wish to assist her and other patients like her, have filed this lawsuit claiming that the self- administration requirement violates the Americans with Disabilities Act (ADA). But because allowing physicians to help people ingest aid-in-dying medication would fundamentally alter the Act, the plaintiffs have not stated a claim under the ADA. The complaint is therefore dismissed in its entirety. I A In 2015, California enacted the End of Life Option Act, which permits qualifying terminally ill people to receive prescriptions for medication that will bring about their death. Cal. Health & Safety Code § 443 et seq. The legislation was polarizing, eliciting passionate responses both in support and opposition from religious groups, medical practitioners, and activists— including those advocating for disability rights. In the face of this controversy, policymakers took pains to craft a statutory framework that would provide choice and peace to many, while acknowledging the weighty moral issues involved and protecting against abuse and coercion. To that end, the Act carefully regulates the prescription and administration of aid-in- dying medication, limiting who can be prescribed such medication and how they can take it. To be eligible for a prescription, a person must have an “incurable and irreversible” disease that will “result in death within six months.” § 443.1(r); § 443.2(a). Additionally, physicians may only prescribe the medication to qualifying people who have “the physical and mental ability to self- administer the aid-in-dying drug.” § 443.2(a)(5). The Act also sets out a series of hurdles that otherwise qualified people must clear. Before they can receive a prescription, a person must “submit two oral requests, a minimum of 48 hours apart,” along with a written request. § 443.3(a). The written request must be signed and dated in the presence of two witnesses, each of whom must attest that the person “voluntarily” signed the request and is “of sound mind and not under duress, fraud, or undue influence.” § 443.3(b)(2), (3). Before prescribing the medication, the attending physician must determine that their patient has the capacity to make medical decisions, has a terminal disease, and has requested the medicine voluntarily. § 443.5(a)(1)(A), (B), (C). The physician must also discuss the “potential risks” of taking the medicine with their patient, along with the “possibility” that the patient “may choose to obtain the aid-in-dying drug but not take it.” § 443.5(a)(2)(B), (D). But the Act’s promise of choice would be an empty gesture had it not also granted criminal and civil immunity to prescribing physicians. In California, any person “who deliberately aids, advises, or encourages another to commit suicide is guilty of a felony.” Cal. Penal Code § 401(a). Accordingly, the Act provides immunity for certain forms of assistance people may receive along the way. Physicians who prescribe medication in accordance with the Act are immune from criminal, civil, and professional liability or discipline. Cal. Health & Safety Code § 443.14(c). Civil and criminal immunity also extend to those who “assist the qualified individual by preparing the aid in dying drug,” so long as they do not assist them “in ingesting” the drug. § 443.14(a) (emphasis added); see also Cal. Penal Code § 401(b). B Sandra Morris is a California resident who has amyotrophic lateral sclerosis (ALS), a disease that destroys nerve cells in the brain and spinal cord, causing progressive loss of muscle control.1 ALS is fatal, and there is no cure. Morris wants the option of taking aid-in-dying medication in the future, although she does not wish to do so now. However, due to the nature of her illness, she may lose this option soon. While Morris currently has the physical ability to self- administer the aid-in-dying medication without assistance, she will likely lack the hand strength and coordination to take the medication on her own in the near future. Morris seeks to represent a class of similarly situated individuals: Californians who qualify for the Act but may lose, or have already lost, the ability to self-administer medication because of the progressive nature of their illness.2 The other named plaintiffs in this action—Lonny Shavelson, Robert Uslander, Gary Pasternak, and Richard Mendius—are California physicians who wish to help their disabled patients ingest aid-in-dying medication. Each has witnessed the way that the Act’s prohibition on assistance places many people in a gut-wrenching position, forced to choose between acting sooner, while they are physically able to administer the medication on their own, or waiting, and risk losing the ability to take the medication and enduring the prolonged sort of death they wished to avoid. They seek to represent a class of physicians who provide aid-in-dying care to patients with progressive, terminal illnesses.

1 The facts described in this section come from the well-pleaded allegations in the complaint. As required at this early stage, all inferences are drawn in favor of the plaintiffs. Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 555–56 (2007). 2 The complaint was also brought on behalf of a second patient plaintiff: Rhiannon Cerreto. However, Cerreto died between the briefing of this motion and this order. See Dkt. No. 78. The Court therefore does not consider the allegations in the complaint concerning Cerreto. The plaintiffs argue that the Hobson’s choice presented to Morris and people like her is not just excruciating—it is unlawful. According to Morris, the Act’s prohibition on assistance violates the ADA by denying her the ability to take aid-in-dying medication because of her physical disabilities. Further, the physicians argue that the Act unlawfully prevents them from helping disabled patients take aid-in-dying medication. The plaintiffs argue that the Act violates the Rehabilitation Act for the same reasons. The plaintiffs have therefore sued those tasked with criminally prosecuting people under California Penal Code Section 401(a): Robert Bonta, the Attorney General of California, and Nancy O’Malley, the Alameda County District Attorney, along with the State of California. The plaintiffs seek a declaration that the assistance prohibition violates the ADA and the Rehabilitation Act, as well as an injunction prohibiting criminal prosecution of physicians who help their eligible disabled patients ingest aid-in-dying medication. The defendants have moved to dismiss the complaint for lack of subject-matter jurisdiction and failure to state a claim. II The defendants argue that this Court lacks jurisdiction to hear the case because the plaintiffs do not have standing under Article III.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ex Parte Young
209 U.S. 123 (Supreme Court, 1908)
Younger v. Harris
401 U.S. 37 (Supreme Court, 1971)
Babbitt v. United Farm Workers National Union
442 U.S. 289 (Supreme Court, 1979)
Alexander v. Choate
469 U.S. 287 (Supreme Court, 1985)
Virginia v. American Booksellers Assn., Inc.
484 U.S. 383 (Supreme Court, 1988)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Washington v. Glucksberg
521 U.S. 702 (Supreme Court, 1997)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Altria Group, Inc. v. Good
555 U.S. 70 (Supreme Court, 2008)
Tyrone Merritt v. County of Los Angeles
875 F.2d 765 (Ninth Circuit, 1989)
Castellano v. City of New York
946 F. Supp. 249 (S.D. New York, 1996)
Christina McClellan v. I-Flow Corporation
776 F.3d 1035 (Ninth Circuit, 2015)
TransUnion LLC v. Ramirez
594 U.S. 413 (Supreme Court, 2021)
Thomas v. Anchorage Equal Rights Commission
220 F.3d 1134 (Ninth Circuit, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
Shavelson, M.D. v. California Department of Health Care Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/shavelson-md-v-california-department-of-health-care-services-cand-2022.